Autopsy report · NCT01239758
Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy
Cause of deathSafety
“This study was terminated based on preliminary safety data.”
Life of this trial
- Ran for about 7 months before it stopped.
- 11 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
- Sponsor type
- Industry
- Conditions
- Duchenne Muscular Dystrophy
- Interventions
- ACE-031 (Extension of cohort 1 from core study, A031-03); ACE-031 (Extension of cohort 2 from core study, A031-03); ACE-031 (Extension of cohort 3 from core study, A031-03)
- Participants
- 11
- Sites
- 4
- Countries
- Canada
Trials that died the same way
- Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
“Study terminated based on evaluation of safety data.” - A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration
“The study terminated for safety reasons” - Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole
“This study was terminated for reasons not related to efficacy or safety” - Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus
“The study was terminated in the interest of patient safety.” - A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Hematologic Malignancies (MK-8628-005)
“This study was terminated due to limited efficacy and not due to safety reasons”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.